T1 Mapping; 4-D Flow Measurements; Myocardial Storage Diseases; Myocarditis; Compressed Sensing

Busse A, Rajagopal R, Yücel S, et al. Cardiac MRI—update 2020. Der Radiologe 2020; 60(1): 33–40. doi: 10.1007/s00117-020- 00687-1. von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. Journal of Cardiovascular Magnetic Resonance 2015; 18(1): 1–18. Yang ACY, Kretzler M, Sudarski S, et al. Sparse reconstruction techniques in MRI: Methods, applications, and challenges to clinical adoption. Investigative Radiology 2016; 51(6): 349–364. Otazo R, Kim D, Axel L, et al. Combination of compressed sensing and parallel imaging for highly accelerated first-pass cardiac perfusion MRI. Magnetic Resonance in Medicine 2010; 64(3): 767–776. Usman M, Atkinson D, Odille F, et al. Motion corrected compressed sensing for free-breathing dynamic cardiac MRI. Magnetic Resonance in Medicine 2013; 70(2): 504–516. Kim D, Dyvorne HA, Otazo R, et al. Accelerated phase-contrast cine MRI using k-t SPARSE-SENSE. Magnetic Resonance in Medicine 2012; 67(4): 1054–1064. Iyer SK, Tasdizen T, Burgon N, et al. Compressed sensing for rapid late gadolinium enhanced imaging of the left atrium: A preliminary study. Magnetic Resonance Imaging 2016; 34(7): 846–854. Mehta BB, Chen X, Bilchick KC, et al. Accelerated and navigator-gated look-locker imaging for cardiac T1 estimation (ANGIE): Development and application to T1 mapping of the right ventricle. Magnetic Resonance in Medicine 2015; 73(1): 150–160. Feng L, Axel L, Chandarana H, et al. XD-GRASP: Golden-angle radial MRI with reconstruction of extra motion-state dimensions using compressed sensing. Magnetic Resonance in Medicine 2016; 75(2): 775–788. Kramer CM, Barkhausen J, Bucciarelli-Ducci C, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. Journal of Cardiovascular Magnetic Resonance 2020; 22(1): 1–18. Becker MAJ, Cornel JH, Van de Ven PM, et al. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: A review and meta-analysis. JACC: Cardiovascular Imaging 2018; 11(9): 1274–1284. Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). Journal of Cardiovascular Magnetic Resonance 2017; 19(1): 1–24. Messroghli DR, Radjenovic A, Kozerke S, et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magnetic Resonance in Medicine 2004; 52(1): 141–146. Piechnik SK, Ferreira VM, Dall’Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. Journal of Cardiovascular Magnetic Resonance 2010; 12(1): 1–11. Haaf P, Garg P, Messroghli DR, et al. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: A comprehensive review. Journal of Cardiovascular Magnetic Resonance 2017; 18(1): 1–12. Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance—2020 update. Journal of Cardiovascular Magnetic Resonance 2020; 22(1): 1–22. doi: 10.1186/s12968-020-00610-6. Martinez-Naharro A, Kotecha T, Norrington K, et al. Native T1 and extracellular volume in transthyretin amyloidosis. JACC: Cardiovascular Imaging 2019; 12(5): 810–819. Sado DM, Flett AS, Banypersad SM, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012; 98(19): 1436–1441 McAlindon E, Pufulete M, Lawton C, et al. Quantification of infarct size and myocardium at risk: Evaluation of different techniques and its implications. European Heart Journal-Cardiovascular Imaging 2015; 16(7): 738–746. McAlindon EJ, Pufulete M, Harris JM, et al. Measurement of myocardium at risk with cardiovascular MR: Comparison of techniques for edema imaging. Radiology 2015; 275(1): 61–70. Giri S, Shah S, Xue H, et al. Myocardial T2 mapping with respiratory navigator and automatic nonrigid motion correction. Magnetic Resonance in Medicine 2012; 68(5): 1570–1578. von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, et al. Myocardial T1 and T2 mapping at 3 T: Reference values, influencing factors and implications. Journal of Cardiovascular Magnetic Resonance 2013; 15(1): 53. Nayak KS, Nielsen JF, Bernstein MA, et al. Cardiovascular magnetic resonance phase contrast imaging. Journal of Cardiovascular Magnetic Resonance 2015; 17(1): 1–26. Dyverfeldt P, Bissell M, Barker AJ, et al. 4D flow cardiovascular magnetic resonance consensus statement. Journal of Cardiovascular Magnetic Resonance; 2015 17(1): 1–19. Ha H, Kim GB, Kweon J, et al. Hemodynamic measurement using four-dimensional phase-contrast MRI: Quantification of hemodynamic parameters and clinical applications. Korean Journal of Radiology 2016; 17(4): 445–462. Hope MD, Sedlic T, Dyverfeldt P. Cardiothoracic magnetic resonance flow imaging. Journal of Thoracic Imaging, 2013, 28(4): 217-230. Guzzardi DG, Barker AJ, Van Ooij P, et al. Valve-related hemodynamics mediate human bicuspid aortopathy: Insights from wall shear stress mapping. Journal of the American College of Cardiology 2015; 66(8): 892–900. Reiter G, Reiter U, Kovacs G, et al. Blood flow vortices along the main pulmonary artery measured with MR imaging for diagnosis of pulmonary hypertension. Radiology 2015; 275(1): 71–79. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 2018; 39(2): 119–177. Salerno M. Feature tracking by CMR: A “double feature”? JACC: Cardiovascular Imaging 2018; 11(2 Part 1): 206–208. Claus P, Omar AMS, Pedrizzetti G, et al. Tissue tracking technology for assessing cardiac mechanics: Principles, normal values, and clinical applications. JACC: Cardiovascular Imaging 2015; 8(12): 1444–1460. Taylor RJ, Moody WE, Umar F, et al. Myocardial strain measurement with feature-tracking cardiovascular magnetic resonance: Normal values. European Heart Journal—Cardiovascular Imaging 2015; 16(8): 871–881. Zghaib T, Ghasabeh MA, Assis FR, et al. Regional strain by cardiac magnetic resonance imaging improves detection of right ventricular scar compared with late gadolinium enhancement on a multimodality scar evaluation in patients with arrhythmogenic right ventricular cardiomyopathy. Circulation: Cardiovascular Imaging 2018; 11(9): e007546. Tello K, Dalmer A, Vanderpool R, et al. Cardiac magnetic resonance imaging-based right ventricular strain analysis for assessment of coupling and diastolic function in pulmonary hypertension. JACC: Cardiovascular Imaging 2019; 12(11 Part 1): 2155–2164. Augusto JB, Nordin S, Vijapurapu R, et al. Myocardial edema, myocyte injury, and disease severity in Fabry disease. Circulation: Cardiovascular Imaging 2020; 13(3): e010171. Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016; 133(24): 2404–2412. Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—Evidence base and standardized methods of imaging. Journal of Nuclear Cardiology 2019; 26(6): 2065–2123. Martinez-Naharro A, Treibel T A, Abdel-Gadir A, et al. Magnetic resonance in transthyretin cardiac amyloidosis. Journal of the American College of Cardiology 2017; 70(4): 466–477. Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert recommendations. Journal of the American College of Cardiology; 2018; 72(24): 3158–3176. White JA, Hansen R, Abdelhaleem A, et al. Natural history of myocardial injury and chamber remodeling in acute myocarditis: A 12-month prospective cohort study using cardiovascular magnetic resonance imaging. Circulation: Cardiovascular Imaging 2019; 12(7): e008614. doi: 10.1161/CIRCIMAGING.118.008614. Aquaro GD, Ghebru Habtemicael Y, Camastra G, et al. Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis. Journal of the American College of Cardiology 2019; 74(20): 2439–2448. Mayr A, Kitterer D, Latus J, et al. Evaluation of myocardial involvement in patients with connective tissue disorders: A multi-parametric cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance 2017; 18(1): 1–13. Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. Cardiovascular Imaging 2020; 13(11): 2330–2339. Inciardi R M, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiology 2020; 5(7): 819–824. Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiology 2020; 5(11): 1308. doi: 10.1001/jamacardio.2020.3557. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: The task force for the diagnosis and management of chronic coronary syndromes of the European society of cardiology (ESC). European Heart Journal 2020; 41(3): 407–477. Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial. The Lancet 2012; 379(9814): 453–460. Greenwood JP, Ripley DP, Berry C, et al. Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: The CE-MARC 2 randomized clinical trial. Jama 2016; 316(10): 1051–1060. Nagel E, Greenwood JP, McCann GP, et al. Magnetic resonance perfusion or fractional flow reserve in coronary disease. New England Journal of Medicine 2019; 380(25): 2418–2428. Kwong RY, Ge Y, Steel K, et al. Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain. Journal of the American College of Cardiology 2019; 74(14): 1741–1755. Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal 2021; 42(14): 1289–1367. doi: 10.1093/eurheartj/ehaa575. Kammerlander AA, Wiesinger M, Duca F, et al. Diagnostic and prognostic utility of cardiac magnetic resonance imaging in aortic regurgitation. JACC: Cardiovascular Imaging 2019; 12(8 Part 1): 1474–1483. Cochran CD, Yu S, Gakenheimer-Smith L, et al. Identifying risk factors for massive right ventricular dilation in patients with repaired tetralogy of Fallot. The American Journal of Cardiology 2020; 125(6): 970–976. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. European Heart Journal 2021; 42(6): 563–645. doi: 10.1093/eurheartj/ehaa554. Reiter U, Reiter G, Fuchsjäger M. MR phase-contrast imaging in pulmonary hypertension. The British Journal of Radiology 2016; 89(1063): 20150995.